Image

    Case Report: Bimekizumab for Dissecting Cellulitis of the Scalp

    May 2026 in “ Frontiers in Immunology
    David Seiter
    Studysummary This case report documents the first use of bimekizumab as monotherapy for dissecting cellulitis of the scalp, where a 27-year-old man experienced significant symptom relief without adverse effects after failing standard treatments.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Dissecting Cellulitis of the Scalp: A Case Report Cureus · 2026
    2. Off-Label Use of Biologics and Janus Kinase Inhibitors for Scarring Alopecias: A Narrative Review Archives of Dermatological Research · 2025
    3. A Systematic Review of Tumor Necrosis Factor-α Blockers, Anti-Interleukins, and Small Molecule Inhibitors for Dissecting Cellulitis of the Scalp Treatment Orphanet Journal of Rare Diseases · 2025
    4. Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib Journal of Inflammation Research · 2025
    5. Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm Dermatology and therapy · 2023
    6. The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside Frontiers in immunology · 2020
    7. Acne Keloidalis Nuchae: Prevalence, Impact, and Management Challenges Clinical, Cosmetic and Investigational Dermatology · 2016